3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Thrombocythemia, Essential
1
Recurrence
1
Primary Myelofibrosis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Interventions
Azacitidine
62
Cyclophosphamide
49
fludarabine phosphate
46
fludarabine
46
Cytarabine
33
Decitabine
32
venetoclax
27
Tacrolimus
21
Specimen Handling
20
Whole-Body Irradiation
19
Mycophenolic Acid
19
Melphalan
19
Filgrastim
19
Busulfan
19
Imatinib Mesylate
18
ruxolitinib
17
Dasatinib
14
Biopsy
14
Antilymphocyte Serum
14
Granulocyte Colony-Stimulating Factor
13
Etoposide
13
Clofarabine
13
Peripheral Blood Stem Cell Transplantation
12
Sirolimus
11
Methotrexate
11
Injections
11
Thiotepa
10
Stem Cell Transplantation
10
Ipilimumab
10
thymoglobulin
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
INCB057643
×
Myeloid
×
Clear all
NCT04279847
2026-04-01
LIMBER
Incyte Corporation
Phase 1
Active not recruiting
140 enrolled